Skip to main content
Molecular Therapy. Nucleic Acids logoLink to Molecular Therapy. Nucleic Acids
. 2022 Mar 8;28:32–34. doi: 10.1016/j.omtn.2022.01.001

HIF-1α or HOTTIP/CTCF Promotes Head and Neck Squamous Cell Carcinoma Progression and Drug Resistance by Targeting HOXA9

Qiang Sun, Shuai-Yuan Zhang, Jun-Fang Zhao, Xin-Guang Han, Hai-Bin Wang, Ming-Lei Sun
PMCID: PMC8914264  PMID: 35317203

Main text

(Molecular Therapy: Nucleic Acids 20, 164–175; June 2020)

In the originally published version of this article, the authors accidentally reversed the values for tumor weight in the bar graph for KB cells transfected with sh-NC or sh-CTCF in Figure 6F. The correct version of the graph is shown below. The authors regret this error.

graphic file with name gr6c.jpg

Figure 6. Knockdown of CTCF Inhibits Cell Proliferation, Migration, Invasion, and Chemoresistance in CAL-27 and KB Cells (corrected)

graphic file with name gr6o.jpg

Figure 6. Knockdown of CTCF Inhibits Cell Proliferation, Migration, Invasion, and Chemoresistance in CAL-27 and KB Cells (original)


Articles from Molecular Therapy. Nucleic Acids are provided here courtesy of The American Society of Gene & Cell Therapy

RESOURCES